Hydatidiform mole in a 39-year-old woman
CMAJ. 2022 Sep 12;194(35):E1215. doi: 10.1503/cmaj.220185.NO ABSTRACTPMID:36096503 | PMC:PMC9477249 | DOI:10.1503/cmaj.220185 (Source: Canadian Medical Association Journal)
Source: Canadian Medical Association Journal - September 12, 2022 Category: General Medicine Authors: Aziz Slaoui Aicha Kharbach Aziz Baydada Source Type: research
Epidemiologic study on gestational trophoblastic diseases in Japan
CONCLUSION: The incidence of hydatidiform mole, low-risk GTN, high-risk GTN was 2.02 per 1,000 live births, 15.3 per 100,000 live births, and 3.4 per 100,000 live births, respectively. High-risk GTN was diagnosed more pathologically and later after the antecedent pregnancy than low-risk GTN. Following molar patients for five years is needed to improve the mortality of malignant GTN.PMID:36047375 | DOI:10.3802/jgo.2022.33.e72 (Source: Journal of Gynecologic Oncology)
Source: Journal of Gynecologic Oncology - September 1, 2022 Category: OBGYN Authors: Eiko Yamamoto Kimihiro Nishino Kaoru Niimi Kazuhiko Ino Source Type: research
